Though RBI maintained its accommodative stance in the MPC meeting, but do you think, it hints towards a further hike in repo rates in the future? Let’s find out. 

As per O’Neil methodology, the buyer demand is A, which indicates strong institutional interest. The FPI/FPI investors have increased their holding from 30.59 in September 2020 quarter to 32.78 per cent in December 2020 quarter. Similarly, the mutual funds have increased holdings from 9.53 per cent in September 2020 quarter to 10.42 per cent in December 2020 quarter.

Biocon Biologics, a fully-integrated biosimilars company and a subsidiary of Biocon Limited announced that it has signed an agreement with Clinton Health Access Initiative to expand access to lifesaving cancer biosimilars in over 30 countries in Africa and Asia as a part of Cancer Access Partnership (CAP).   

The key economic news on India for the week ended February 5, 2021.

Given the fact that the stock has started to outperform in the recent past on the back of a huge volume spike certainly indicates interest for this stock; however, it has reached a very crucial juncture. This juncture is known as a ‘change in polarity’. The principle of change in polarity states that once breached, a support level becomes resistance and vice-versa i.e. the resistance level becomes support. 

One of the most crucial things that many of the market participants tend to overlook when they buy a stock for a short-term trading purpose or for an investment purpose is the delivery volume. The stocks that are a part of Nifty 500 are considered and the total volume traded should be greater than 1,00,000. Further, the total volume traded should be greater than the previous session.

The company anticipates bringing products based on CTPR in near term that would be affordable and accessible to farmers across India. 

Kellton Tech Solution Ltd today announced that it has launched a one-stop, cloud-based, and intelligent building management system with the name, KeLive.

Zydus Cadila, a global leading pharmaceutical company, today announced that it has completed patient enrolment in DREAM-ND and DREAM-D Phase III trials of Desidustat. 

The stock of KPIT Technologies Limited has been picked up by our Bollinger Band Squeeze scanner, which suggests that the stock is near a consolidation breakout.